Skip to main content
. 2020 Aug 20;64(9):e00703-20. doi: 10.1128/AAC.00703-20

TABLE 2.

Comparison of infections by isolates with and without CzIE

Characteristic Clinical and microbiologic valuesa related to isolates:
P value
With CzIE (n = 36) Without CzIE (n = 214)
Age (yrs) 10.4 (6.9–11.9) 9.1 (5.1–12.2) 0.38
Female gender 13 (36.1) 87 (40.6) 0.71
Race 0.82
    White 30 (83.3) 153 (71.4)
    Black 5 (13.8) 43 (20.1)
    Asian 0 6 (2.8)
    Otherb 0 5 (2.3)
    Unknown/not disclosed 1 (2.7) 7 (3.3)
Hispanic ethnicity 10 (27.8) 61 (28.5) 1
Duration of symptoms on presentation (days) 4.5 (2–7) 5 (3–7) 0.52
Admission CRPc (mg/dl) 4.6 (3.8–7.7) 6.6 (3.7–15.5) 0.21
Multifocal infection 3 (8.3) 7 (3.3) 0.16
Subperiosteal/intraosseous abscess 17 (47.2) 85 (39.7) 0.46
Maximum abscess diameterd (cm) 2.9 (1.1–4) 3 (1.5–5.8) 0.3
Surgical procedure performed 20 (55.5) 136 (63.5) 0.36
≥2 surgical procedures performede 2 (5.6) 43 (20.1) 0.04
Delayed first source controlf 5 (13.8) 23 (10.7) 0.57
ICU admission 1 (2.7) 12 (5.6) 0.7
Positive blood culture 26 (72.2) 118 (55.1) 0.07
Duration of bacteremia (days) 1 (1–2) 1 (1–2) 0.39
Duration of fever after admission (days) 3 (2–4) 3 (2–4) 0.37
Definitive treatment with 1GC 30 (83.3) 159 (74.3) 0.29
Discharge on oral antibiotics 20 (55.6) 105 (49.1) 0.58
Length of stay (days) 6 (5–10) 6 (5–9) 0.9
Duration of follow-up (days) 68 (39–494) 77 (35–247) 0.32
Progression to chronic osteomyelitis 5 (13.8) 8 (3.7) 0.03
Clindamycin resistance 9 (25) 20 (9.3) 0.01
PVLg positive 5 (13.8) 47 (21.9) 0.38
Vancomycin MIC of >1 μg/ml 12 (33.3) 100 (46.7) 0.15
agrIh 13 (36.1) 140 (65.4) 0.001
agrII 2 (5.6) 31 (14.5) 0.19
agrIII 19 (52.7) 21 (9.8) <0.001
agrIV 1 (2.7) 8 (3.7) 1
agr nontypeable 1 (2.7) 14 (6.5) 0.7
a

All continuous variables are presented as medians with interquartile ranges; categorical variables are presented as n (%).

b

Other with regard to race includes Native American/Alaskan Native, Native Hawaiian/Pacific Islander, and self-identified multiple races.

c

CRP, C-reactive protein.

d

Only 61 cases had abscess size documented.

e

The number of surgical procedures performed refers only to those performed during the index admission.

f

Delayed source control was defined as >3 calendar days from the time of admission until first surgical source control.

g

PVL, Panton-Valentine leucocidin.

h

agr refers to accessory gene regulator group.